Andrea F.  Wainer net worth and biography

Andrea Wainer Biography and Net Worth

Andrea Wainer is Abbott’s Executive Vice President, Rapid and Molecular Diagnostics. She was appointed to this role in June 2019.

Andrea joined Abbott in 1997 and served in a variety of roles within our pharmaceuticals business, including divisional vice president and general manager, renal care. She then led our Animal Health business, which was acquired by Zoetis in February 2015. Immediately prior to assuming her current responsibilities, Andrea served as Vice President, Molecular Diagnostics.  

In her current role, Andrea leads two innovative businesses; one a leader in molecular diagnostics and the analysis of DNA and RNA at the molecular level; the other the world’s leading provider of rapid point-of-care diagnostics. Each of these offers products that provide clinicians with actionable information that can contribute to better clinical, operational and economic outcomes.

Andrea earned her bachelor’s degree in accounting from the John M. Olin School of Business, Washington University, St. Louis, Missouri, and her Masters in Business Administration from the Kellogg School of Management, Northwestern University in Evanston, Illinois.

What is Andrea F. Wainer's net worth?

The estimated net worth of Andrea F. Wainer is at least $8.19 million as of February 23rd, 2024. Ms. Wainer owns 78,704 shares of Abbott Laboratories stock worth more than $8,192,299 as of May 19th. This net worth evaluation does not reflect any other assets that Ms. Wainer may own. Learn More about Andrea F. Wainer's net worth.

How do I contact Andrea F. Wainer?

The corporate mailing address for Ms. Wainer and other Abbott Laboratories executives is 100 ABBOTT PARK ROAD D-322 AP6D, ABBOTT PARK IL, 60064. Abbott Laboratories can also be reached via phone at (224) 667-6100. Learn More on Andrea F. Wainer's contact information.

Has Andrea F. Wainer been buying or selling shares of Abbott Laboratories?

Andrea F. Wainer has not been actively trading shares of Abbott Laboratories over the course of the past ninety days. Most recently, Andrea F. Wainer sold 12,500 shares of the business's stock in a transaction on Friday, February 23rd. The shares were sold at an average price of $120.00, for a transaction totalling $1,500,000.00. Following the completion of the sale, the executive vice president now directly owns 78,704 shares of the company's stock, valued at $9,444,480. Learn More on Andrea F. Wainer's trading history.

Who are Abbott Laboratories' active insiders?

Abbott Laboratories' insider roster includes Hubert Allen (Insider), Roxanne Austin (Director), Roger Bird (SVP), Brian Blaser (Insider), Philip Boudreau (VP), Sharon Bracken (Insider), John Capek (EVP), Jaime Contreras (SVP), Michael Dale (SVP), Lisa Earnhardt (EVP), Robert Ford (Chairman), Robert Ford (CEO), Robert Funck (CFO), Stephen Fussell (EVP), John Ginascol (EVP), Sammy Karam (SVP), Michelle Kumbier (Director), Andrew Lane (EVP), Joseph Manning (SVP), John Mccoy Jr. (VP), Nancy Mckinstry (Director), Mary Moreland (EVP), Louis Morrone (SVP), Phebe Novakovic (Director), Michael Pederson (SVP), Daniel Salvadori (EVP), Christopher Scoggins (SVP), Daniel Starks (Director), Julie Tyler (SVP), Andrea Wainer (EVP), Jared Watkin (SVP), Miles White (Chairman), Randel Woodgrift (SVP), and Brian Yoor (CFO). Learn More on Abbott Laboratories' active insiders.

Are insiders buying or selling shares of Abbott Laboratories?

During the last year, insiders at the healthcare product maker sold shares 10 times. They sold a total of 214,784 shares worth more than $23,037,977.79. The most recent insider tranaction occured on May, 10th when EVP Jr. Robert E Funck sold 10,097 shares worth more than $1,055,843.29. Insiders at Abbott Laboratories own 1.1% of the company. Learn More about insider trades at Abbott Laboratories.

Information on this page was last updated on 5/10/2024.

Andrea F. Wainer Insider Trading History at Abbott Laboratories

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/23/2024Sell12,500$120.00$1,500,000.0078,704View SEC Filing Icon  
1/29/2024Sell42,500$112.50$4,781,250.0065,027View SEC Filing Icon  
12/14/2023Sell15,000$108.00$1,620,000.0065,027View SEC Filing Icon  
8/8/2023Sell10,400$105.03$1,092,312.0065,027View SEC Filing Icon  
5/2/2023Sell8,226$110.56$909,466.5670,427View SEC Filing Icon  
3/1/2023Sell679$100.70$68,375.3070,427View SEC Filing Icon  
3/1/2022Sell456$118.13$53,867.28View SEC Filing Icon  
12/27/2021Sell3,000$142.50$427,500.00View SEC Filing Icon  
12/23/2021Sell13,000$140.00$1,820,000.00View SEC Filing Icon  
12/17/2021Sell7,500$137.54$1,031,550.00View SEC Filing Icon  
12/13/2021Sell14,500$135.00$1,957,500.00View SEC Filing Icon  
12/6/2021Sell4,500$132.50$596,250.00View SEC Filing Icon  
9/2/2021Sell9,500$127.50$1,211,250.00View SEC Filing Icon  
8/17/2021Sell14,500$125.00$1,812,500.0054,282View SEC Filing Icon  
3/3/2021Sell6,200$121.79$755,098.0051,550View SEC Filing Icon  
3/1/2021Sell587$120.61$70,798.0758,337View SEC Filing Icon  
9/30/2020Sell30,000$107.01$3,210,300.0074,080View SEC Filing Icon  
9/23/2020Sell3,650$102.47$374,015.5044,080View SEC Filing Icon  
2/7/2020Sell1,120$88.61$99,243.2040,140View SEC Filing Icon  
See Full Table

Andrea F. Wainer Buying and Selling Activity at Abbott Laboratories

This chart shows Andrea F Wainer's buying and selling at Abbott Laboratories by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Abbott Laboratories Company Overview

Abbott Laboratories logo
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.
Read More

Today's Range

Now: $104.09
Low: $103.94
High: $104.80

50 Day Range

MA: $109.59
Low: $104.00
High: $120.76

2 Week Range

Now: $104.09
Low: $89.67
High: $121.64

Volume

7,004,500 shs

Average Volume

5,643,946 shs

Market Capitalization

$181.08 billion

P/E Ratio

32.43

Dividend Yield

2.11%

Beta

0.76